Comparison Guide
Mounjaro Side Effects UK — Complete Guide & Cheaper Alternatives
Mounjaro (tirzepatide) is one of the most talked-about weight management medications in the UK. This guide covers the published side effect profile from clinical trials, what to expect, and how research-grade tirzepatide compares in laboratory settings.
Mounjaro is the brand name for tirzepatide — a dual GLP-1/GIP receptor agonist developed by Eli Lilly. It received MHRA approval in the UK in 2023 for type 2 diabetes management and in 2024 for weight management under the brand Twinseta. Private prescription Mounjaro costs £1,050–£1,400 per month in the UK.
| Side Effect | Frequency | Severity |
|---|---|---|
| Nausea | Very common (>30%) | Mild–Moderate |
| Diarrhoea | Common (20–30%) | Mild–Moderate |
| Vomiting | Common (15–20%) | Mild |
| Constipation | Common (10–15%) | Mild |
| Reduced appetite | Very common | Expected effect |
| Injection site reactions | Common (5–10%) | Mild |
| Fatigue | Common | Mild |
| Pancreatitis | Rare | Serious |
GLP-1 receptors are present throughout the gastrointestinal tract. Activation slows gastric emptying — which is why appetite is reduced, but also why nausea and GI discomfort are common. Tirzepatide's GIP component partially offsets this compared to pure GLP-1 agonists like semaglutide, which is why Mounjaro is generally better tolerated than Ozempic in clinical comparisons.
In Phase 2 trials, retatrutide demonstrated a comparable GI side effect profile to tirzepatide, with the glucagon component potentially causing additional nausea at higher doses. However, the superior efficacy data suggests retatrutide achieves greater metabolic modulation for equivalent tolerability.
At £1,050–£1,400/month, Mounjaro is expensive on private prescription. Alluvi Healthcare supplies research-grade tirzepatide (the active molecule in Mounjaro) from £115 per 40mg box — strictly for laboratory research and development applications. This is not a therapeutic product and is not equivalent to or a substitute for prescribed Mounjaro.
| Product | Price | Use |
|---|---|---|
| Mounjaro (Tirzepatide) — Private Rx | £1,050–£1,400/month | Therapeutic — MHRA approved |
| Alluvi Tirzepatide 40mg (R&D) | From £115/box | Research only — not therapeutic |
| Alluvi Retatrutide 40mg (R&D) | From £195/box | Research only — not therapeutic |
Alluvi Healthcare supplies independently verified research peptides with full COA, cold chain delivery and UK-based support. Batch AR0763RT4 — 99.38% purity.